WEST LAFAYETTE, Ind. - A company based at Purdue Research Park has received $15 million for its work on technology designed to boost the amount of cancerous tissue surgeons can remove.
West Lafayette-based OnTarget Laboratories LLC announced Tuesday that it's received the funding from the Pension Fund of the Christian Church and Old World Industries founder Tom Hurvis.
Hurvis, who's the company's original investor, says OnTarget's technology "could be a game-changer in helping patients with cancer" if it's successful.
The new funding will go toward additional clinical trials needed to optimize technology developed by OnTarget that causes cancerous tissues to light up with fluorescent imaging during surgery. Company officials say illuminating that tissue could enable surgeons to remove more of cancerous tumors during surgeries, possibly improving patients' survival rates.